These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 21266233
1. Activation of the unfolded protein response in human acute myeloid leukemia. Schardt JA, Mueller BU, Pabst T. Methods Enzymol; 2011; 489():227-43. PubMed ID: 21266233 [Abstract] [Full Text] [Related]
2. Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia. Schardt JA, Eyholzer M, Timchenko NA, Mueller BU, Pabst T. J Cell Mol Med; 2010 Jun; 14(6B):1509-19. PubMed ID: 19659458 [Abstract] [Full Text] [Related]
3. Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AML. Haefliger S, Klebig C, Schaubitzer K, Schardt J, Timchenko N, Mueller BU, Pabst T. Blood; 2011 Jun 02; 117(22):5931-40. PubMed ID: 21471526 [Abstract] [Full Text] [Related]
4. Activation of the unfolded protein response is associated with favorable prognosis in acute myeloid leukemia. Schardt JA, Weber D, Eyholzer M, Mueller BU, Pabst T. Clin Cancer Res; 2009 Jun 01; 15(11):3834-41. PubMed ID: 19470730 [Abstract] [Full Text] [Related]
5. Complexity of CEBPA dysregulation in human acute myeloid leukemia. Pabst T, Mueller BU. Clin Cancer Res; 2009 Sep 01; 15(17):5303-7. PubMed ID: 19706798 [Abstract] [Full Text] [Related]
6. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia. Pabst T, Eyholzer M, Haefliger S, Schardt J, Mueller BU. J Clin Oncol; 2008 Nov 01; 26(31):5088-93. PubMed ID: 18768433 [Abstract] [Full Text] [Related]
7. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Moore MA, Dorn DC, Schuringa JJ, Chung KY, Morrone G. Exp Hematol; 2007 Apr 01; 35(4 Suppl 1):105-16. PubMed ID: 17379095 [Abstract] [Full Text] [Related]
8. Transcriptional dysregulation during myeloid transformation in AML. Pabst T, Mueller BU. Oncogene; 2007 Oct 15; 26(47):6829-37. PubMed ID: 17934489 [Abstract] [Full Text] [Related]
9. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features. Szankasi P, Ho AK, Bahler DW, Efimova O, Kelley TW. Leuk Res; 2011 Feb 15; 35(2):200-7. PubMed ID: 20970189 [Abstract] [Full Text] [Related]
10. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T. Clin Cancer Res; 2005 Feb 15; 11(4):1416-24. PubMed ID: 15746041 [Abstract] [Full Text] [Related]
11. Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent. Song LP, Zhang J, Wu SF, Huang Y, Zhao Q, Cao JP, Wu YL, Wang LS, Chen GQ. Oncogene; 2008 Jan 17; 27(4):519-27. PubMed ID: 17637739 [Abstract] [Full Text] [Related]
12. PU.1 and CEBPA expression in acute myeloid leukemia. D'Alò F, Di Ruscio A, Guidi F, Fabiani E, Greco M, Rumi C, Hohaus S, Voso MT, Leone G. Leuk Res; 2008 Sep 17; 32(9):1448-53. PubMed ID: 18308386 [Abstract] [Full Text] [Related]
13. Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2. Snaddon J, Smith ML, Neat M, Cambal-Parrales M, Dixon-McIver A, Arch R, Amess JA, Rohatiner AZ, Lister TA, Fitzgibbon J. Genes Chromosomes Cancer; 2003 May 17; 37(1):72-8. PubMed ID: 12661007 [Abstract] [Full Text] [Related]
14. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG. Nat Genet; 2001 Mar 17; 27(3):263-70. PubMed ID: 11242107 [Abstract] [Full Text] [Related]
15. K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML). Carnicer MJ, Lasa A, Buschbeck M, Serrano E, Carricondo M, Brunet S, Aventin A, Sierra J, Di Croce L, Nomdedeu JF. Ann Hematol; 2008 Oct 17; 87(10):819-27. PubMed ID: 18587575 [Abstract] [Full Text] [Related]
16. Capillary gel electrophoresis: a simple method for identification of mutations and polymorphisms in the CEBPA gene in patients with acute myeloid leukaemia. Juhl-Christensen C, Bomberg M, Melsvik D, Hokland P, Nyvold CG. Eur J Haematol; 2008 Oct 17; 81(4):273-80. PubMed ID: 18616509 [Abstract] [Full Text] [Related]
17. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. Green CL, Koo KK, Hills RK, Burnett AK, Linch DC, Gale RE. J Clin Oncol; 2010 Jun 01; 28(16):2739-47. PubMed ID: 20439648 [Abstract] [Full Text] [Related]
18. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W, Zhang DE, Tenen DG. Nat Med; 2001 Apr 01; 7(4):444-51. PubMed ID: 11283671 [Abstract] [Full Text] [Related]
19. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. Fröhling S, Schlenk RF, Stolze I, Bihlmayr J, Benner A, Kreitmeier S, Tobis K, Döhner H, Döhner K. J Clin Oncol; 2004 Feb 15; 22(4):624-33. PubMed ID: 14726504 [Abstract] [Full Text] [Related]
20. Complexity of miR-223 regulation by CEBPA in human AML. Eyholzer M, Schmid S, Schardt JA, Haefliger S, Mueller BU, Pabst T. Leuk Res; 2010 May 15; 34(5):672-6. PubMed ID: 20018373 [Abstract] [Full Text] [Related] Page: [Next] [New Search]